HALOZYME THERAPEUTICS, INC. Deferred Revenue, Revenue Recognized
HALOZYME THERAPEUTICS, INC. (HALO) reported Deferred Revenue, Revenue Recognized of $4.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2020-02-24
- HALOZYME THERAPEUTICS, INC. deferred revenue, revenue recognized for the quarter ending 2018-09-30 was $500.00K.
- HALOZYME THERAPEUTICS, INC. deferred revenue, revenue recognized for the quarter ending 2018-03-31 was $1.80M.
- HALOZYME THERAPEUTICS, INC. deferred revenue, revenue recognized for fiscal 2019 was $4.00M, a 42.86% increase from fiscal 2018.
- HALOZYME THERAPEUTICS, INC. deferred revenue, revenue recognized for fiscal 2018 was $2.80M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2019-12-31 | $4.00M 10-K · filed 2020-02-24 | |||
| 2018-12-31 | $2.80M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $500.00K 10-Q · filed 2018-11-06 | $2.30M 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | $1.80M 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | $1.80M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |